All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

One-year outcomes of patients with the zotarolimus-eluting coronary stent: RESOLUTE International Registry

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F12%3A43906907" target="_blank" >RIV/00216208:11120/12:43906907 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064173:_____/12:43906907

  • Result on the web

    <a href="http://dx.doi.org/10.4244/EIJV7I10A189" target="_blank" >http://dx.doi.org/10.4244/EIJV7I10A189</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.4244/EIJV7I10A189" target="_blank" >10.4244/EIJV7I10A189</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    One-year outcomes of patients with the zotarolimus-eluting coronary stent: RESOLUTE International Registry

  • Original language description

    To provide clinical outcome data from everyday practice for the new generation Resolute zotarolimus-eluting stent (R-ZES). Methods and results: Patients were eligible if placement of >= 1 R-ZES was intended. There were no restrictions on clinical indication, number of treated vessels, and lesion characteristics. The primary endpoint was the adjudicated cumulative 1-year incidence of cardiac death and target vessel myocardial infarction. Twenty-five per cent of the patients were randomly selected for monitoring. We recruited 2,349 patients with 3,147 lesions (1.6 +/- 1.0 steins per patient); 46.0% of patients had acute coronary syndrome, 30.5% were diabetic, and >= 1 complex criterion for stent placement was present in 67.5% of patients. One-year follow-up was complete in 97.9% of patients. The I-year incidence of the primary endpoint was 4.3% (95% CI: 3.5% to 5.2%) and for ARC definite and probable stern thrombosis, 0.9% (0.5% to 1.3%). Clinically driven target lesion revascularisation

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FA - Cardiovascular diseases including cardio-surgery

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2012

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    EuroIntervention

  • ISSN

    1774-024X

  • e-ISSN

  • Volume of the periodical

    7

  • Issue of the periodical within the volume

    10

  • Country of publishing house

    FR - FRANCE

  • Number of pages

    9

  • Pages from-to

    1181-1188

  • UT code for WoS article

    000301616900010

  • EID of the result in the Scopus database